153 related articles for article (PubMed ID: 28045920)
1. Alterations in Evoked Otoacoustic Emissions by the Use of Meglumine Antimoniate in American Tegumentary Leishmaniasis Patients.
Oliveira Bezerra DC; Oliveira de Barcelos R; Carvalho de Castro E; Jardim Duarte CC; de Vasconcellos Carvalhaes Oliveira R; Salgado de Sousa Torraca T; de Araújo-Melo MH; Pereira Bom Braga F; Ramos Ferreira Terceiro B; do Nascimento Brahim Paes LR; de Oliveira Schubach A; Valete-Rosalino CM
PLoS One; 2017; 12(1):e0168492. PubMed ID: 28045920
[TBL] [Abstract][Full Text] [Related]
2. Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children.
Stavroulaki P; Apostolopoulos N; Segas J; Tsakanikos M; Adamopoulos G
Int J Pediatr Otorhinolaryngol; 2001 May; 59(1):47-57. PubMed ID: 11376818
[TBL] [Abstract][Full Text] [Related]
3. First report on ototoxicity of meglumine antimoniate.
Valete-Rosalino CM; Araujo-Melo MH; Bezerra DC; Barcelos RO; Melo-Ferreira Vd; Torraca TS; Martins AC; Moreira JS; Vargas MC; Braga FP; Salgueiro Mde M; Saheki MN; Schubach AO
Rev Inst Med Trop Sao Paulo; 2014; 56(5):439-42. PubMed ID: 25229226
[TBL] [Abstract][Full Text] [Related]
4. Increased prevalence of early cochlear damage in young patients with type 1 diabetes detected by distortion product otoacoustic emissions.
Botelho CT; Carvalho SA; Silva IN
Int J Audiol; 2014 Jun; 53(6):402-8. PubMed ID: 24564623
[TBL] [Abstract][Full Text] [Related]
5. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
Hoth S
Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
[TBL] [Abstract][Full Text] [Related]
6. Chirp-Evoked Otoacoustic Emissions and Middle Ear Absorbance for Monitoring Ototoxicity in Cystic Fibrosis Patients.
Garinis AC; Keefe DH; Hunter LL; Fitzpatrick DF; Putterman DB; McMillan GP; Gold JA; Feeney MP
Ear Hear; 2018; 39(1):69-84. PubMed ID: 28708814
[TBL] [Abstract][Full Text] [Related]
7. Otoacoustic emissions--an approach for monitoring aminoglycoside induced ototoxicity in children.
Stavroulaki P; Apostolopoulos N; Dinopoulou D; Vossinakis I; Tsakanikos M; Douniadakis D
Int J Pediatr Otorhinolaryngol; 1999 Nov; 50(3):177-84. PubMed ID: 10595663
[TBL] [Abstract][Full Text] [Related]
8. Transient-evoked otoacoustic emissions in a group of professional singers who have normal pure-tone hearing thresholds.
Hamdan AL; Abouchacra KS; Zeki Al Hazzouri AG; Zaytoun G
Ear Hear; 2008 Jun; 29(3):360-77. PubMed ID: 18382377
[TBL] [Abstract][Full Text] [Related]
9. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia].
Lisowska G; Namysłowski G; Hajduk A; Polok A; Tomaszewska R; Misiołek M
Otolaryngol Pol; 2006; 60(3):415-20. PubMed ID: 16989457
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Hidden Hearing Loss in Normal Hearing Individuals with and Without Tinnitus.
Kara E; Aydın K; Akbulut AA; Karakol SN; Durmaz S; Yener HM; Gözen ED; Kara H
J Int Adv Otol; 2020 Apr; 16(1):87-92. PubMed ID: 32209515
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the possible effect of magnetic resonance imaging noise on peripheral hearing organ with the otoacoustic emission.
Turay CB; Ozer F; Yildirim T; Erbek S
Am J Otolaryngol; 2020; 41(6):102586. PubMed ID: 32629148
[TBL] [Abstract][Full Text] [Related]
12. [Patterns of hearing disorders in normal otoacoustic emissions].
Xu J; Huang W; Liu G; Zhou J; Gao B
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Nov; 19(22):1023-5. PubMed ID: 16468152
[TBL] [Abstract][Full Text] [Related]
13. A longitudinal study of changes in evoked otoacoustic emissions and pure-tone thresholds as measured in a hearing conservation program.
Lapsley Miller JA; Marshall L; Heller LM
Int J Audiol; 2004 Jun; 43(6):307-22. PubMed ID: 15457813
[TBL] [Abstract][Full Text] [Related]
14. On a possible prognostic value of otoacoustic emissions: a study on patients with sudden hearing loss.
Hoth S
Eur Arch Otorhinolaryngol; 2005 Mar; 262(3):217-24. PubMed ID: 15133692
[TBL] [Abstract][Full Text] [Related]
15. Assessing Sensorineural Hearing Loss Using Various Transient-Evoked Otoacoustic Emission Stimulus Conditions.
Putterman DB; Keefe DH; Hunter LL; Garinis AC; Fitzpatrick DF; McMillan GP; Feeney MP
Ear Hear; 2017; 38(4):507-520. PubMed ID: 28437273
[TBL] [Abstract][Full Text] [Related]
16. An investigation of hearing impairment in de-novo Parkinson's disease patients: A preliminary study.
Pisani V; Sisto R; Moleti A; Di Mauro R; Pisani A; Brusa L; Altavista MC; Stanzione P; Di Girolamo S
Parkinsonism Relat Disord; 2015 Aug; 21(8):987-91. PubMed ID: 26071125
[TBL] [Abstract][Full Text] [Related]
17. Transient evoked otoacustic emissions and distortion product in school children.
Vasconcelos RM; Serra LS; Aragão VM
Braz J Otorhinolaryngol; 2008; 74(4):503-7. PubMed ID: 18852974
[TBL] [Abstract][Full Text] [Related]
18. Otoacoustic emissions in a hearing conservation program: general applicability in longitudinal monitoring and the relation to changes in pure-tone thresholds.
Helleman HW; Jansen EJ; Dreschler WA
Int J Audiol; 2010 Jun; 49(6):410-9. PubMed ID: 20192875
[TBL] [Abstract][Full Text] [Related]
19. [Possibility for quantitative and frequency-specific assessment of auditory threshold with otoacoustic emissions].
Dreher A; Suckfüll M; Schneeweiss S; Schorn K
Laryngorhinootologie; 1997 Jan; 76(1):2-7. PubMed ID: 9156504
[TBL] [Abstract][Full Text] [Related]
20. Changes in otoacoustic emissions and high-frequency hearing thresholds in children and adolescents.
Groh D; Pelanova J; Jilek M; Popelar J; Kabelka Z; Syka J
Hear Res; 2006 Feb; 212(1-2):90-8. PubMed ID: 16364580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
